Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing

Since September 2010, over 10,000 patients have undergone preemptive, panel-based pharmacogenomic testing through the Vanderbilt Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment (PREDICT) program. Analysis of the genetic data from the first 9,589 individuals reveals the frequenc...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Van Driest, Sara L., Shi, Yaping, Bowton, Erica A., Schildcrout, Jonathan S., Peterson, Josh F., Pulley, Jill, Denny, Josh C., Roden, Dan M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3961508/
https://ncbi.nlm.nih.gov/pubmed/24253661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2013.229
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg